These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20077006)

  • 41. The mental health expert patient: findings from a pilot study of a generic chronic condition self-management programme for people with mental illness.
    Lawn S; Battersby MW; Pols RG; Lawrence J; Parry T; Urukalo M
    Int J Soc Psychiatry; 2007 Jan; 53(1):63-74. PubMed ID: 17333952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Community mental health team management in severe mental illness: a systematic review.
    Simmonds S; Coid J; Joseph P; Marriott S; Tyrer P
    Br J Psychiatry; 2001 Jun; 178():497-502; discussion 503-5. PubMed ID: 11388964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Illness management and recovery (IMR) in Danish community mental health centres.
    Dalum HS; Korsbek L; Mikkelsen JH; Thomsen K; Kistrup K; Olander M; Hansen JL; Nordentoft M; Eplov LF
    Trials; 2011 Aug; 12():195. PubMed ID: 21849024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial.
    Drake RE; McHugo GJ; Clark RE; Teague GB; Xie H; Miles K; Ackerson TH
    Am J Orthopsychiatry; 1998 Apr; 68(2):201-15. PubMed ID: 9589759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adding consumer-providers to intensive case management: does it improve outcome?
    Rivera JJ; Sullivan AM; Valenti SS
    Psychiatr Serv; 2007 Jun; 58(6):802-9. PubMed ID: 17535940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Processes underlying treatment success and failure in assertive community treatment.
    Stull LG; McGrew JH; Salyers MP
    J Ment Health; 2012 Feb; 21(1):49-56. PubMed ID: 22142361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Participants' lived experience of pursuing personal goals in the Illness Management and Recovery program.
    Jensen SB; Eplov LF; Mueser KT; Petersen KS
    Int J Soc Psychiatry; 2021 Jun; 67(4):360-368. PubMed ID: 32907440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study.
    McHugo GJ; Drake RE; Teague GB; Xie H
    Psychiatr Serv; 1999 Jun; 50(6):818-24. PubMed ID: 10375153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assertive community treatment in the Netherlands: outcome and model fidelity.
    van Vugt MD; Kroon H; Delespaul PA; Dreef FG; Nugter A; Roosenschoon BJ; van Weeghel J; Zoeteman JB; Mulder CL
    Can J Psychiatry; 2011 Mar; 56(3):154-60. PubMed ID: 21443822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Costs and outcome of assertive community treatment (ACT) in a rural area in Denmark: 4-year register-based follow-up.
    Hastrup LH; Aagaard J
    Nord J Psychiatry; 2015 Feb; 69(2):110-7. PubMed ID: 25131794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The psychometric properties of the Illness Management and Recovery scale: client and clinician versions.
    Hasson-Ohayon I; Roe D; Kravetz S
    Psychiatry Res; 2008 Aug; 160(2):228-35. PubMed ID: 18599126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The work of recovery on two assertive community treatment teams.
    Salyers MP; Stull LG; Rollins AL; Hopper K
    Adm Policy Ment Health; 2011 May; 38(3):169-80. PubMed ID: 20839045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of illness management and recovery (IMR) in the Netherlands: a randomised clinical trial.
    Roosenschoon BJ; Mulder CL; Deen ML; van Weeghel J
    BMC Psychiatry; 2016 Mar; 16():73. PubMed ID: 26995361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment outcome in patients receiving assertive community treatment.
    Kortrijk HE; Mulder CL; Roosenschoon BJ; Wiersma D
    Community Ment Health J; 2010 Aug; 46(4):330-6. PubMed ID: 19847646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Providing assertive community treatment for severely mentally ill patients in a rural area.
    Santos AB; Deci PA; Lachance KR; Dias JK; Sloop TB; Hiers TG; Bevilacqua JJ
    Hosp Community Psychiatry; 1993 Jan; 44(1):34-9. PubMed ID: 8436358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Model fidelity and team members' experiences of assertive community treatment in Norway: a sequential mixed-methods study.
    Odden S; Landheim A; Clausen H; Stuen HK; Heiervang KS; Ruud T
    Int J Ment Health Syst; 2019; 13():65. PubMed ID: 31636700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Employment outcomes for clients with severe mental illness in a PACT model replication. Program for Assertive Community Treatment.
    Becker RE; Meisler N; Stormer G; Brondino MJ
    Psychiatr Serv; 1999 Jan; 50(1):104-6. PubMed ID: 9890590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic limit setting in an assertive community treatment program.
    Neale MS; Rosenheck RA
    Psychiatr Serv; 2000 Apr; 51(4):499-505. PubMed ID: 10737826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of flexible assertive community treatment in Denmark: a quasi-experimental controlled study.
    Nielsen CM; Hjorthøj C; Killaspy H; Nordentoft M
    Lancet Psychiatry; 2021 Jan; 8(1):27-35. PubMed ID: 33091344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and reliability of a measure of clinician competence in providing illness management and recovery.
    McGuire AB; Stull LG; Mueser KT; Santos M; Mook A; Rose N; Tunze C; White LM; Salyers MP
    Psychiatr Serv; 2012 Aug; 63(8):772-8. PubMed ID: 22854724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.